Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Health Improvements by Understanding the Determinants of Residual Risk in Coronary Artery Disease and New Targets for Prevention and Treatment

View source ↗

Summary

An update on an ongoing clinical trial investigating determinants of residual risk in coronary artery disease and identifying new prevention and treatment targe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione Toscana Gabriele Monasterio | Conditions: Coronary Arterial Disease (CAD) | Status: RECRUITING